Rivaroxaban CAS 366789-02-8 Kuchena > 99.5% (HPLC) Factory API High Quality
Manufacturer Supply Rivaroxaban Related Intermediates:
(S)-(+)-Glycidyl Phthalimide CAS 161596-47-0
4-(4-Aminophenyl)morpholin-3-imwe CAS 438056-69-0
Rivaroxaban Yepakati CAS 446292-07-5
5-Chlorothiophene-2-Carboxylic Acid CAS 24065-33-6
5-Chlorothiophene-2-Carbonyl Chloride CAS 42518-98-9
Rivaroxaban API CAS 366789-02-8
Chemical Name | Rivaroxaban |
Mashoko anoreva zvakafanana | (S)-Rivaroxaban;(S) -5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carbox;BAY 59-7939 |
Nhamba yeCAS | 366789-02-8 |
Stock Status | MuStock, Kugadzirwa Kunokwira Kusvika Matani |
Molecular Formula | C19H18ClN3O5S |
Molecular Weight | 435.88 |
Brand | Ruifu Chemical |
Item | Zvinotsanangurwa |
Chitarisiko | Upfu Huchena kana Hunenge Huchena |
Identification A | Iyo infrared absorption yeRivaroxaban inoenderana nereferenzi zviyero |
Kuzivikanwa B | Iyo nguva yekuchengeta yepamusoro peak yemuenzaniso mhinduro inoenderana neiyo yegadziriro yekukodzera mhinduro, sezvakawanikwa mukuchena kweenantiomeric. |
Enantiomeric Purity | RVX RC01: ≤0.15% |
Kunyorova (KF) | ≤0.50% |
Sulfated Ash | ≤0.10% |
Heavy Metals | ≤20ppm |
Acetic Acid | ≤5000ppm |
Zvinhu zvinoenderana (HPLC) | |
RVX RC02 | ≤0.15% |
RVX RC03 | ≤0.15% |
RVX RC04 | ≤0.15% |
RVX RC05 | ≤0.15% |
RVX RC06 | ≤0.15% |
RVX RC07 | ≤0.15% |
RVX RC08 | ≤0.15% |
Chero Kumwe Kusachena Kwemunhu | ≤0.10% |
Zvose Zvisina Kuchena | <0.50% |
Residual Solvents (GC) | |
Ethanol | ≤5000ppm |
Toluene | ≤890ppm |
Triethylamine | ≤320ppm |
Kuchena / Analysis Method | > 99.5% (HPLC) (pane anhydrous basis) |
Test Standard | Enterprise Standard |
Usage | API;Antithrombotic Drug;FXa Inhibitor |
Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.
Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza uye unyoro.
Rivaroxaban(CAS:366789-02-8) (Xarelto, Bayer) is an oral anticoagulant.Iyo inobata nemuromo yakananga factor Xa inhibitor.Rivaroxaban inoratidzwa nokuda kwe'kurapa kwe-deep vein thrombosis uye pulmonary embolism, nekudzivirira kwekudzoka kwakadzika mutsinga thrombosis uye pulmonary embolism muvakuru'.Nekuda kwekutanga kurapwa kweacute pulmonary embolism, iyo yakakurudzirwa dosage ye rivaroxaban ndeye 15 mg kaviri zuva nezuva kwemazuva ekutanga e21 inoteverwa ne 20 mg kamwe chete zuva nezuva kuti irambe ichirapwa uye kudzivirira kudzokororwa kwevenous thromboembolism.Non-Valvular Atrial Fibrillation (NVAF) kudzivirira sitiroko & systemic embolism.Acute VTE kurapwa & kudzivirira inodzokororwa VTE [yeyakadzika vein thrombosis (DVT) uye pulmonary embolism (PE)].Kudzivirirwa kwevenous thromboembolic zviitiko (VTE) mukusarudzwa kwese hudyu kana kutsiva ibvi kuvhiya (THR, TKR).